Forms and Documents
- Confirmation of clinical diagnosis
- Distinguish among the various forms of primary immunodeficiency
- Determination of appropriate treatment, including instituting prophylaxis
- Carrier testing in female relatives of affected males
- Prenatal diagnosis in at-risk pregnancies
*Reporting times are typical, but could be extended in situations outside GeneDx's reasonable control.
- 279.04 Congenital hypogammaglobulinemia, Agammaglobulinemia: Bruton's type X-linked
- 279 Disorders involving the immune mechanism
**The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
- Conley ME et al, 2005, Genetic analysis of patients with defects in early B-cell development, Immunological Reviews 203:216.
- Mutations of the human BTK gene coding for Bruton tyrosine Kinase in X-linked agammaglobulinemia, 1999, Vihinen, M et al, Human Mutation 13:280-285.